|
|
 |

Background
Introduction: West Nile (WN) virus has emerged in recent years in temperate regions of
Europe and North America, presenting a threat to public, equine,
and animal health. The most serious manifestation
of WN virus infection is fatal encephalitis (inflammation of the brain) in humans and
horses, as well as mortality in certain domestic and wild birds.
History: West Nile virus was first isolated from a febrile adult woman in the West
Nile District of Uganda in 1937. The ecology was characterized in Egypt in the
1950s. The virus became recognized as a cause of severe human
meningoencephalitis (inflammation of the spinal cord and brain) in elderly
patients during an outbreak in Israel in 1957. Equine disease was first noted
in Egypt and France in the early 1960s. The appearance of WN virus in North America
in 1999, with encephalitis reported in humans and horses, may be an important
milestone in the evolving history of this virus.
 |
 |
| |
|
Geographic Distribution: West Nile virus has been described in Africa, Europe, the Middle East, west
and central Asia, Oceania (subtype Kunjin), and most recently, North America.
Recent outbreaks of WN virus encephalitis in humans have occurred in Algeria in
1994, Romania in 1996-1997, the Czech Republic in 1997, the Democratic Republic
of the Congo in 1998, Russia in 1999, the United States in 1999-2000, and Israel
in 2000. Epizootics
of disease in horses occurred in Morocco in 1996, Italy in 1998, the United
States in 1999-2000, and France in 2000. In the U.S. through September
2000, WN virus has been documented in Connecticut, Maryland, Massachusetts, New
Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and the
District of Columbia.
Classification:
- Family: Flaviviridae
- Genus: Flavivirus Japanese Encephalitis Antigenic Complex
- P.O. Box 2087
Fort Collins, Colorado,
80522
|